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Background: The role of flagellin glycosylation is not well understood.
Results: The Burkholderia cenocepacia flagellin is glycosylated on at least 10 different sites.
Conclusion: The presence of glycan in flagellin significantly impaired the inflammatory response of epithelial cells.
Significance: Flagellin glycosylation reduces recognition of flagellin by host TLR5, providing an evasive strategy to infecting
bacteria.
Burkholderia cenocepacia is an opportunistic pathogen
threatening patients with cystic fibrosis. Flagella are required
for biofilm formation, as well as adhesion to and invasion of
epithelial cells. Recognitionof flagellin via theToll-like receptor
5 (TLR5) contributes to exacerbateB. cenocepacia-induced lung
epithelial inflammatory responses. In this study, we report that
B. cenocepacia flagellin is glycosylated on at least 10 different
sites with a single sugar, 4,6-dideoxy-4-(3-hydroxybutanoyl-
amino)-D-glucose. We have identified key genes that are
required for flagellin glycosylation, including a predicted glyco-
syltransferase gene that is linked to the flagellin biosynthesis
cluster and a putative acetyltransferase gene located within the
O-antigen lipopolysaccharide cluster. Another O-antigen clus-
ter gene, rmlB, which is required for flagellin glycan and O-an-
tigen biosynthesis, was essential for bacterial viability, uncover-
ing a novel target against Burkholderia infections. Using
glycosylated and nonglycosylated purified flagellin and a cell
reporter system to assess TLR5-mediated responses, we also
show that the presence of glycan in flagellin significantly
impairs the inflammatory response of epithelial cells.We there-
fore suggest that flagellin glycosylation reduces recognition of
flagellin by host TLR5, providing an evasive strategy to infecting
bacteria.
Burkholderia cenocepacia is a Gram-negative bacterium
belonging to the B. cepacia complex. This group of opportunis-
tic pathogens poses a health threat to patients with cystic fibro-
sis (1, 2). Chronic airway infection of these patients with the B.
cepacia complex bacteria, particularly B. cenocepacia, acceler-
ates the decay of lung function and in some cases leads to a
lethal necrotizing pneumonia known as “cepacia syndrome”
(3). B. cepacia complex infections have also been reported in
nosocomial outbreaks not related to cystic fibrosis (4–7).
Together with Burkholderia multivorans, B. cenocepacia
accounts for the majority of B. cepacia complex infections in
cystic fibrosis patients (8, 9). B. cenocepacia encompasses at
least four phylogenetic lineages, IIIA to IIID, but most of the
cystic fibrosis isolates belong to lineage IIIA and IIIB (10, 11).
The clonal lineage ET12 belongs to the IIIA group, and these
bacteriawere responsible formost of the deaths related to cepa-
cia syndrome in the early 1980s (3, 12, 13).
B. cenocepacia K56-2 is an ET12 strain that carries various
virulence factors, including lipopolysaccharide (LPS) and fla-
gella. The LPS from K56-2 has been intensively studied in our
laboratory (14–18) and consists of lipid A, core oligosaccha-
ride, and polymeric O-antigen (19). The K56-2 O-antigen is a
polymer of a trisaccharide-repeating unit containing rhamnose
and twoN-acetylgalactosamine residues (15). In general, LPS is
a potent proinflammatory molecule, and the K56-2 O-antigen
influences phagocytosis by human macrophages and interferes
with bacterial adherence to bronchial epithelial cells (18, 20).
Flagella are organelles for bacterial motility, but they are also
involved in pathogenicity (21) such as adhesion to and invasion
of epithelial cells, and biofilm formation (22–26). Flagella con-
sist of a basal body, flagellar hook, and a filament built of flagel-
lin monomers, which are specifically recognized by the innate
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immune system via the Toll-like receptor 5 (TLR5)2 (26, 27).
Toll-like receptors are membrane-bound pattern-recognition
receptors in epithelial and immune cells, which play an essen-
tial role in initiating innate immune responses (28). TLRs rec-
ognize pathogen-derived microbial molecules (pathogen-asso-
ciated molecular patterns) like LPS (TLR4) or flagellin (TLR5).
Engagement of TLR by its specific ligand initiates an intracel-
lular signaling cascade leading to the activation of nuclear
factor B (NF-B) and members of the MAPK family. These
signaling pathways subsequently activate transcription of pro-
inflammatory cytokines like interleukin-1 (IL-1), IL-6, IL-8, and
tumor necrosis factor  (TNF-). The TLR5 signaling pathway
plays a pivotal role in exacerbating lung inflammation in cystic
fibrosis (29), and it is responsible for B. cenocepacia-induced
lung epithelial inflammatory response (30). Furthermore, a
mutation leading to reduced activating capacity of the TLR5
was associated with reduced organ failure and improved sur-
vival in patients infected with Burkholderia pseudomallei,
another important pathogen of the genus Burkholderia (31),
underscoring the critical role of TLR5 and its ligand in human
infection.
B. cenocepacia strains produce two types of flagellin, type I
and II, distinguished by the molecular size of the protein and
restriction fragment length polymorphism analyses (32).
Flagellin in B. cenocepacia K56-2 belongs to type II, and these
bacteria carry a single long polar flagellum that contributes to
virulence in amouse infectionmodel and induces host immune
responses via TLR5 (26). B. pseudomallei and Burkholderia
thailandensis produce glycosylated flagellin (33), but the glyco-
sylation status of flagellin in B. cenocepacia is unknown. In this
work, we report that B. cenocepacia flagellin filaments are post-
translationallymodified by glycosylation atmultiple sites with a
single glycan residue and identify the key genes responsible for
this modification. We also demonstrate that flagellin glycosyl-
ation reduces the ability of this protein to trigger TLR5-medi-
ated inflammatory responses in epithelial cells.
EXPERIMENTAL PROCEDURES
Strains and Chemicals—The strains used in this study are
listed in Table 1. Bacteria were grown either on 1.5% agar plates
or in LB broth (Lennox) at 37 °C. When required, antibiotics
2 The abbreviations used are: TLR5, Toll-like receptor 5; D-Qui4N(3HOBut),
4,6-dideoxy-4-(3-hydroxybutanoylamino)-D-glucose.
TABLE 1
Strains and plasmids used in this study
Name Description Source
Strains
B. cenocepacia
K56-2 ET12 clone related to J2315, cystic fibrosis clinical isolate BCRRCa (2, 73)
RSF44 K56-2, fliCD 38
MH1K K56-2, amrABC (BCAL1674–1676); Gms 74
BCAL3119–3131 MH1K, wbiI-wzm This study
BCAL3123–3124 MH1K, wbxCD This study
BCAL0111 MH1K, flmQ (flagellin glycan glycosyltransferase) This study
BCAL0110 MH1K, BCAL0110 (vioA paralogue in the fliC gene cluster) This study
BCAS0105 MH1K, BCAS0105 (rmlD paralogue in chromosome 3) This study
BCAS0105 pSC200/rmlD MH1K, BCAS0105, containing Prha::rmlD This study
BCAL3129 MH1K, vioA This study
XOA10 K56-2, Prha::BCAL1928 17
XOA11 K56-2, Prha::arnT 17
MH43 MH1K, wbxD (BCAL3124) M. Hamad
MH1K pSC200/rmlD MH1K, Prha::rmlD This study
MH1K pSC200/rmlB MH1K, Prha::rmlB This study
MH1K pSC200/rmlC MH1K, Prha::rmlC This study
MH1K pSC200/BCAL0111 MH1K, Prha::BCAL0111 This study
BCAL3123–3124 pIN62/BCAL3123 MH1K, wbxCD; wbxC This study
E. coli
GT115 FmcrA  (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 rpsL endA1
dcm uidA (MluI)::pir-116 sbcC-sbcD; used as donor strain
Laboratory stock
SY327 araD (lac pro) argE(Am) recA56 nalA  pir; Rifr; used as helper strain 75
Plasmids
pRK2013 Helper plasmid used for bacterial conjugation; Kanr 76
pGPI-SceI-2 Suicide vector used for genetic manipulation of B. cenocepacia; Tpr 14
pDAI-SceI-SacB Replicative vector expressing I-SceI homing endonuclease; Tetr 74
pIN62 Broad host range replicative vector expressing DSRed, Cmr 40
pGPTp Suicide vector used for genetic manipulation of B. cenocepacia; Tpr 39
pSC200 Rhamnose-inducible vector used for depletion experiments; Tpr 17
pGPI-SceI-2/BCAL3119–3131 Suicide vector used to delete O-antigen cluster This study
pGPI-SceI-2/BCAL3123–3124 Suicide vector used to delete wbxC and wbxD This study
pGPI-SceI-2/BCAL0111 Suicide vector used to delete BCAL0111 This study
pGPI-SceI-2/BCAL0110 Suicide vector used to delete BCAL0110 This study
pGPI-SceI-2/BCAS0105 Suicide vector used to delete BCAS0105 This study
pGPI-SceI-2/BCAL3129 Suicide vector used to delete vioA homologue in O-antigen cluster This study
pGPTp/rmlD Vector used to create gene disruption in rmlD (BCAL3132) This study
pSC200/rmlB Prha::rmlB (BCAL3135) This study
pSC200/rmlC Prha::rmlC (BCAL3133) This study
pSC200/rmlD Prha::rmlD (BCAL3132) This study
pSC200/BCAL0111 Prha::BCAL0111 This study
pIN62/BCAL3123 Vector used for complementation of wbxC (BCAL3123) This study
a BCRRC, B. cepacia Research and Referral Repository for Canadian CF Clinics; Cmr, chloramphenicol resistance; Tpr, trimethoprim resistance; Tetr, tetracycline resistance;
Kanr, kanamycin resistance; DSRed, red fluorescent protein from Discosoma sp.
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were added as follows: trimethoprim, 50 g ml1 for Esche-
richia coli and 100 g ml1 for B. cenocepacia; tetracycline, 20
g ml1 for E. coli and 100 g ml1 for B. cenocepacia; kana-
mycin, 40 g ml1 for E. coli; chloramphenicol, 30 g ml1 for
E. coli and 150gml1 forB. cenocepacia. Ampicillin at 200g
ml1 was used during triparental mating to selectively elimi-
nate donor and helperE. coli strains.When required, rhamnose
was added to a final concentration of 0.4% (w/v). Sucrose plates
for the final curing of deletionmutants were prepared with 10 g
liter1 of tryptone, 5 g liter1 of yeast extract, and 50 g liter1 of
sucrose in 1.5% agar. Antibiotics and chemicals were purchased
from Sigma. Growth media were purchased from BD Biosci-
ences. Restriction enzymes, Antarctic phosphatase, and T4
ligase were purchased from New England Biolabs (Ipswich,
MA). HEK293-TLR5 cells expressing human TLR5 were pur-
chased from Invivogen (San Diego), and p-P65, p-ERK, ERK,
p-P38, P38, p-JNK and JNK antibodies were fromCell Signaling
(Danvers, MA). P65 was purchased from Santa Cruz Biotech-
nology (Dallas, TX) and -actin antibody from Sigma.
Isolation of Flagellin—Flagella were isolated as in Brett et al.
(34) with some modifications. Briefly, bacteria were grown for
18 h in 400 ml of LB with antibiotics and/or rhamnose as
required and centrifuged, and the bacterial pellets were frozen
at20 °C overnight. Thawed pellets were next resuspended in
20 ml of PBS, and flagella were sheared off with a homogenizer
(low speed setting for 4min on ice). Cell debris was removed by
centrifugation (6,000  g, 10 min, 4 °C), and flagella were pre-
cipitated overnight from the supernatant with ammonium sul-
fate (end concentration 5%). The precipitate was centrifuged
(12,000  g, 30 min, 4 °C) and the supernatant discarded. The
pellet, containing flagella, was dissolved in 750 l of PBS of
which 250 l were stored at 20 °C for SDS-PAGE analysis
(crude flagellar filaments fraction), and the remaining 500 l
were centrifuged again (16,900 g, 10 min, 4 °C). Flagellar fil-
aments in the sediment were solubilized with 8 M urea; insolu-
ble debris was removed by centrifugation (10,000  g, 1 min),
and the solubilized flagellin was desalted on a HiTrap ÄKTA
FPLC column (GE Healthcare) using either 25 mM ammonium
bicarbonate (prior to structural analyses) or PBS (for biological
tests) as eluents. Soluble and purified flagellin was either stored
at20 °C or lyophilized.
SDS-PAGE andWestern Blot—The purity and the molecular
mass of flagellin were assessed in 14% SDS-polyacrylamide gels
stained with PageBlue protein staining solution (Thermo Sci-
entific). Bio-Rad Precision Plus Dual Color Protein Standard
was used as a molecular weight marker. To visualize glycosy-
lated proteins, the Pro-Q Emerald glycoprotein stain kit was
used according to the manufacturer’s manual (Molecular
Probes). Flagellin was detected on Western blots with pri-
mary polyclonal antibody RFFL/ARP42986_P050 provided
by AVIVA Systems Biology (San Diego) and with secondary
goat anti-rabbit IgG-HRP secondary antibody. The blots were
developed with Western Lightning ECL Pro (PerkinElmer Life
Sciences).
Mass Spectrometry and Enzymatic Digestion—Flagellin was
in-gel digested with trypsin, chymotrypsin, AspN, and a mix-
ture of AspN and trypsin. LCMS/MS mass spectrometry anal-
yses were performed on aWaters QTof global mass spectrom-
eter equipped with a Z-spray (ESI) source and run in positive
ion mode (the instrument was run in DDAmode) in combina-
tion with a Waters nanoAcquity UPLC, and the results were
confirmed with a Thermo Scientific Orbitrap Elite MS (LC-
MS/MS). The Peaks software (Bioinformatics Solutions Inc.)
was used to analyze the digested samples. Waters QTof Micro
withWatersMassLynx 4.1 was used for whole protein analyses.
Flagellinwas analyzed as an intact protein in 25mMammonium
bicarbonate. Lyophilized, digested samples were reconstituted
in 20 l of 0.2% formic acid in water, and 10 l were injected.
Chemical Deglycosylation of Flagellin—Desalted and lyophi-
lized protein (1.5 mg) was chemically deglycosylated by trifluo-
romethanesulfonic acid (35). Briefly, 100 l of a 10% toluene/
trifluoromethanesulfonic acid mixture was slowly added to the
sample in a glass vial placed in a dry ice/ethanol bath. After 2 h,
the mixture was carefully neutralized with 300 l of pyridine
solution (pyridine/methanol/water at a ratio of 3:1:1 v/v/v) for 5
min in a dry ice/ethanol bath, and the sample was transferred to
wet ice for another 15 min. The mixture was transferred into a
plastic 1.5-ml vial, and 400l of 25mMammoniumbicarbonate
was added to precipitate the deglycosylated flagellin. After cen-
trifugation (16,900 g, 10min), the supernatant was discarded,
and the pellet was dissolved in 8 M urea. Further desalting in 25
mM ammonium bicarbonate was performed on a HiTrap col-
umn as described above, and the sample was used directly for
MS analysis.
GC/MS Analyses and -Elimination—Methanolysis was used
to analyze the glycan moiety of flagellin. Briefly, 400 g of the
lyophilized sample was treated with 0.5 M methanolic HCl
(weakmethanolysis) and peracetylated, and an aliquotwas used
to record GC/MS spectra. Next, the same sample was treated
with 2 M methanolic HCl (strong methanolysis), peracetylated,
and analyzed again. To determine the character of the bound
glycosyl residue, another 400 g of lyophilized flagellin was
used for -elimination. Briefly, 400 g of lyophilized sample
were treated with 0.1 M NaOH containing 0.8 M NaBH4 for 8 h
at 37 °C in the dark. Next, the mixture was dried under nitro-
gen, peracetylated, and analyzed. To confirm the conformation
of the sugar, ions detected in GC/MS spectra from B. cenocepa-
cia FliC were compared with GC/MS of the O-antigen sample
from Providencia stuartiiO43 (kindly provided by J. Knirel and
O. Ovchinnikova). The D-configuration of the sugar was deter-
mined by octanolysis (36). Mass spectrometric measurements
were performedwith Agilent Technologies 5975 inert XLMSD
equipped with split/splitless injector system with electron ion-
ization under autotune conditions at 70 eV.
General Molecular Techniques and Genetic Manipulation of
B. cenocepacia—Plasmid vectors and primers are listed in
Tables 1 and 2, respectively. DNA manipulations and cloning
were performed as described previously (37). PCRs were per-
formed with HotStar HiFidelity DNA polymerase (Qiagen).
Plasmid and genomic DNA were isolated using QiaPrep Spin
kit and DNeasy Blood and Tissue kit (Qiagen), respectively.
PCR products were purified using aQIAquick PCR purification
kit or a QIAquick gel extraction kit (Qiagen). Freshly prepared
chemically competent E. coli GT115 cells were transformed by
the calcium chloride method. Plasmids were mobilized into B.
cenocepacia by triparental mating (14, 38).
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Cloning of B. cenocepacia K56-2 fliC—The fliC gene
(BCAL0114) was amplified fromB. cenocepaciaK56-2 genomic
DNA with the primer pair 6093/6094 and sequenced at the
Core Molecular Biology Facility, York University, Toronto,
Canada. The B. cenocepacia K56-2 fliC sequence was sub-
mitted to GenBankTM and is available under accession num-
ber KC763156.
Construction ofMutants in B. cenocepacia—Unmarked dele-
tionmutants were constructed as described previously (14, 38).
Briefly, the target genes were deleted by allelic exchange
using the pGPI-SceI-2 plasmid containing the corresponding
upstream and downstream fragments. The resulting deletion
plasmids were introduced into B. cenocepacia by triparental
mating. Upstream fragments for deletion of the vioA homo-
logue in the O-antigen cluster (BCAL3129), flmQ (BCAL0111),
the vioA homologue in the fliC cluster (BCAL0110), the rmlD
homologue (BCAS0105), the O-antigen cluster between
wbiI and wzm (BCAL3119 to BCAL3131), and wbxC/wbxD
(BCAL3123 to BCAL3124) (15) were amplified with primer
pairs 6165/6166, 5235/5236, L0110 US XbaI/L0110 US NotI,
5922/5923, 5852/5853, and L3123 US BglII/L3123 USNotI and
downstream fragments by 6167/6168, 5237/5238, L0110 DS
NotI/L0110 DS BglII, 5924/5925, 5888/5889, and Q38/Q39,
respectively (Table 2). The insertional inactivation of rmlD
(BCAL3132) was achieved by cloning 300-bp internal frag-
ments from BCAL3132 (amplified using primers pair 5685/
5686; Table 2) into pGPTp. The resulting mutagenesis plas-
mid pGPTp/rmlD was mobilized into B. cenocepacia (39).
Conditional mutants in rmlB (BCAL3135), rmlC (BCAL3133),
rmlD (BCAL3132), and flmQ (BCAL0111) were constructed
using pSC200 (17). The primers used to amplify DNA frag-
ments were as follows: 6021/6022 (rmlB), Q92/Q91 (rmlC),
6023/6024 (rmlD), and Q89/Q90 (flmQ; Table 2). Each ampli-
con contained the NdeI restriction site in the starting codon of
each gene to facilitate cloning into pSC200.
Rhamnose Depletion Assays—Conditional mutants were
grownovernight in 5ml of LBwith trimethoprim (100gml1)
and 0.4% rhamnose. The next day, 1 ml of each strain was cen-
trifuged and washed three times with LB without rhamnose.
The absorbance (A600) was adjusted to 1.0 in LB without rham-
nose, and 3l of each dilution of 101 to 106were incubated at
37 °C on LB agar with trimethoprim with or without 0.4%
rhamnose for 24 h. The essentiality of each respective gene was
also assessed in broth. For this, overnight cultures grown in 5ml
of LB with trimethoprim (100 g ml1) and 0.4% rhamnose
were centrifuged and washed three times in LB without rham-
nose. Each strain was diluted to A600 0.03 in LB/trimethoprim
with or without rhamnose, and triplicates of 300 l were incu-
bated for 4 h in honeycomb plates at 37 °C with shaking using a
Bioscreen (OyGrowthCurves, Finland). Next, 3l of each dilu-
tion were transferred to fresh medium with or without rham-
nose and incubated for an additional 19 h. The A600 was mea-
sured every 30 min. Strains XOA10 (B. cenocepacia K56-2
pSC200/BCAL1928; nonlethal conditional mutant) and XOA11
TABLE 2
Primers used in this study (restriction sites are italicized)
Name Sequence (5 to 3) Restriction site
5235 gattgatgcggccgcgaagccgccatcggcgcgaacccg NotI
5236 gcacctaagatctgccagcatgcgccgtcttgcggg BglII
5237 tagctgagatctggcgcaatcggcaatgagggcgaccag BglII
5238 aacgtgtctagaagtgtggtggtgtcgctgctgagc XbaI
5685 cgtagtgaattcgacggcagcaagcaggcaccttattcgga EcoRI
5686 atcatatctagaccggcacgccgttccgcgagggacttc XbaI
5852 aatgaagatctcgccgccgtgccccatgctcgacgcctg BglII
5853 catatgcggccgcctacaagcacgtgccgctgatggaag NotI
5888 gatcgatgcggccgcacttgaaagacgatcattcccacg NotI
5889 attgctctagacgttttgatgaacgtttcggact XbaI
5922 gcacctaagatctctaccgaaggggcaggccggggctgtt BglII
5923 gtagtcgcggccgccgagtcgaggacgtcgagttcggcg NotI
5924 cagtactctagagtcgtcggacggggggatacggtggtc XbaI
5925 gtagtcgcggccgcccgttacccgacctacacgcccgacgtc NotI
6021 tagctacatatgatcctggttacgggcggcgcggg NdeI
6022 taacgtctagagaacgtgccgaccacgttggtctggac XbaI
6023 tagctgcatatgcgtgaggcaacgatgagctggaaaccg NdeI
6024 atatgtctagacgagccgcgcgctgcggcaacgcgtgcc XbaI
6093 cgggtgatccgggaagttctggatgaagacctggcggc None
6094 aatgaacgagtgcttccgccgacgccaaaacggctttcc None
6165 catagcggccgccttctgcccaccattcgtcaaccacgc NotI
6166 cgactagatctatctaagcatcggtcaggtcgacacatg BglII
6167 catagcggccgcaagcagttcaacgtattcgcgcgtcgc NotI
6168 gtcatctagagctgagcgccgtgttgtatgcggcacatg XbaI
Q38 tcatctagagctcgtcgatttgatcggtacgcgccatac XbaI
Q39 ccttttgcggccgcaatgcccgtattgcgcgcgccagac NotI
Q89 tagctgcatatgatgttctcgaccgaactgcccgccac NdeI
Q90 taacgtctagaccgtttgcccggtgcgatgcagcg XbaI
Q91 tagctacatatgatggccatccaagtaacggtgacagc NdeI
Q92 taacgtctagatcgtccgacaggacaacccccacccac XbaI
L3123 US BglII gactagatctccgtggccattcgtgccacaggcatcc BglII
L3123 US NotI attagcggccgcatcgcgatgctctggcgagacgagcg NotI
L0110 US XbaI agtcatctagattgcgtgcacgctgctcagcgtccgcgg XbaI
L0110 US NotI catagcggccgcgcaagggtgccgttcgcgaacagcgac NotI
L0110 DS NotI catagcggccgcgtcgcgaaccacgcgtatttcccgatc NotI
L0110 DS BglII acgcgttcagatctttcgagttcgacaacagcgcgatgg BglII
L3123 XbaI tagtcatctagattaggccgaccgtttcatcaatggcac XbaI
L3123 NdeI acgctcatatggattggagtgaatgatggagcgaatcgc NdeI
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(B. cenocepacia K56-2 pSC200/arnT; lethal mutation) were
used as controls (17).
Complementation Experiments—Plasmid pIN62 (encoding
chloramphenicol resistance (40)) was used to complement
BCAL3123, which was cloned from B. cenocepacia K56-2
genomic DNA using the L3123 XbaI/L3123 NdeI primer pair
(Table 2). The plasmid and PCR product were digested with
XbaI andNdeI at 37 °C for 16 h. The digested plasmidDNAwas
subsequently dephosphorylated using Antarctic phosphatase
(37 °C, 30 min), which was then deactivated at 65 °C (2 min).
Ligation was performed at 16 °C for 16 h using T4 DNA ligase.
Transformation and triparental mating were performed as
described previously (see text above). The resulting plasmid
pIN62/BCAL3123 (as confirmed by sequencing) was intro-
duced into the appropriateB. cenocepacia strains via triparental
mating.
Whole Cell Lysates and LPS Staining—To determine the
presence of O-antigen, whole cell lysates were prepared and
resolved on 14% SDS-polyacrylamide gels, and LPS was visual-
ized by silver staining as described previously (41), except that
instead of citric acid, a mixture of 2.5% sodium carbonate (w/v)
with 0.05% formaldehyde (v/v) in water heated to 60 °C was
used as developing solution.
Motility Assays and Biofilm Formation—Bacterial motility
was analyzed on soft agar plates (1% Bacto Tryptone in 0.3%
agar). The A600 of overnight cultures was adjusted to 1.0, and 2
l of culture were inoculated in the center of agar plate. The
growth zone diameter was measured after 24 h of incubation at
37 °C. Biofilmmass was quantified by the crystal violet protocol
as described previously (42).
Biological Assays—Flagellin from B. cenocepacia parental
strain and the BCAL0111 deletion mutant was purified in PBS
as described above. The concentration of FliC was confirmed
densitometrically. THP1 cells or HEK293-TLR5 cells were
seeded (2  105 cells ml1; 2 ml) in 12-well plates and stimu-
lated with the indicated concentrations of WT and nonglyco-
sylated flagellin for 24 h. Conditioned medium was then mea-
sured for levels of TNF-, IL-6, IL-8, and IL-1 (DuoSet kits; R
& D Systems) according to the manufacturer’s protocol. For
luciferase reporter assays, HEK293-TLR5 cells were seeded
(1.5 105 cells ml1; 200 l) in 96-well plates and transfected
with constructs encoding NFB-regulated firefly luciferase (80
ng) and the TKRenilla luciferase reporter construct (phRL-TK;
20 ng; Promega Biosciences). Cells were treated as indicated,
and cell lysates were assayed for firefly luciferase activity and
normalized for transfection efficiency using TK Renilla lucifer-
ase activity. Cell extracts were also assayed for phosphorylated
and total levels of p65 and p38, JNK and ERKMAPKs byWest-
ern blotting.
RESULTS
B. cenocepacia Flagellin Is Glycosylated with 4,6-Dideoxy-4-
(3-hydroxybutanoylamino)-D-glucose—Flagella were sheared
off B. cenocepacia cells and solubilized with 8 M urea, as
described under “Experimental Procedures” (Fig. 1A). Mass
spectrometric analyses of tryptic digests confirmed the identity
of the flagellin monomer (FliC). Further MS analyses of native
FliC revealed onemajormolecular ion at 40,836m/z andminor
ions at 40,605, 40,374, 40,143, and 41,067m/z (Fig. 2A). These
masseswere comparedwith the theoreticalmass of FliC fromB.
cenocepacia J2315, which is 38,779.79 Da. Strains J2315 and
K56-2 belong to the ET12 clone, but J2315 was the only ET12
strain sequenced at the time of these experiments (43). Thus,
the observed mass of the major molecular ion was 2,057 Da
larger than expected from the theoretical amino acid sequence.
Moreover, the molecular ions differed from each other by 231
m/z, suggesting the presence of at least five modifications. In
SDS-polyacrylamide gels, FliC was visualized by Coomassie
Blue staining and also reacted with Pro-Q Emerald glycopro-
tein stain, suggesting that the observed modifications were due
to glycosylation. FliC was also detected on Western blot with
the primary antibody RFFL/ARP42986_P050 (Fig. 1, B and C).
To accurately determine themolecularmass of FliC, purified
flagellin was chemically deglycosylated, as indicated under
“Experimental Procedures.” The deglycosylation method was
optimized to specifically cleave glycosidic bonds without dam-
aging the peptide backbone (35). The MS analysis of the degly-
cosylated protein showed a single molecular ion of 38,756.90
m/z (Fig. 2B). This result provided additional evidence that FliC
wasmodified by a glycan. Furthermore,MS of the tryptic digest
confirmed the identity of the deglycosylated protein as FliC,
except that it was 23 Da smaller than expected from the theo-
retical mass of the J2315 FliC (38,779.79 Da). This suggested
that FliC proteins from K56-2 and J2315 were not completely
identical. DNA sequencing of the fliC (BCAL0114) gene from
K56-2 revealed a singleC toA substitution at 1,072 bp, resulting
in a histidine to asparagine replacement at position 358 in the
K56-2 FliC (H358N) giving a 23-Da difference in molecular
mass. The difference in mass between native and chemically
deglycosylated FliCwas also reflected in SDS-PAGE analyses by
Coomassie Blue staining (Fig. 1D). However, deglycosylated
FliC still reacted with Pro-Q Emerald, indicating that this stain
was not specific for the B. cenocepacia FliC glycan.
FIGURE 1. SDS-PAGE andWestern blot analyses of B. cenocepacia FliC. A,
Coomassie-stained SDS-PAGE showing crude flagellar filaments (C), superna-
tant obtained after insoluble flagella were sedimented at 16,000  g for 10
min (S), and purified flagellin after solubilization with 8 M urea and desalting
(P). B, crude flagellar filaments from the B. cenocepacia parental strain (WT)
andBCAL0111 (0111)were analyzedbyWesternblotwith theAVIVARFFL/
ARP42986_P050 antibody. C, Coomassie Blue-stained SDS-PAGE of crude fla-
gellar filaments from B. cenocepacia parental strain (WT) and BCAL0111
(0111) from the samepreparationused inB.D, Coomassie Blue-stainedSDS-
PAGE of chemically deglycosylated (dgWT) and native (WT) flagellin. Arrows
indicate the correspondingmolecularmasses of theprotein standards in kDa.
Flagellin Glycosylation in B. cenocepacia
JULY 4, 2014•VOLUME 289•NUMBER 27 JOURNAL OF BIOLOGICAL CHEMISTRY 19235
 at IR
eL (Natl Univ of Ireland, M
aynooth) on September 10, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Because trypsin digestion alone did not provide sufficient
peptide coverage spanning the entire FliC protein, additional
digestions were performed with chymotrypsin, AspN, and a
mixture of AspN and trypsin.Mass spectra were recorded for
all four digested samples separately, and the combined data
were analyzed, giving 100% sequence coverage. This strategy
allowed us to identify ions matching the peptides with
one or two 231 m/z modifications (Table 3). Thus, the local-
ization of single modifications was assigned to peptides
159DLSQSMSAAK168, 177GQTVGTVTGLSLDNNGAYTGS-
GATITAINVLSDGK211, and 287DISTVSGANVAMVSIDNA-
LQTVNNVQAALGAAQNR321, whereas peptides 212-GGYT-
FTDQNGGAISQTVAQSVF-233, 234GANATTGTGTAVGN-
LTLQ251, and 252SGATGAGTSAAQQTAITNAIAQINAVN-
KPATLVSNL287 carried two modifications. From these
combined results, we could clearly identify 9 out of 10 possible
modification sites (as determined byMS of the entire FliC (Fig.
2, A and D, and Table 3). The exact position of the modificat-
ions in each peptide was not determined.
To identify the nature of the FliC glycan, flagellin was ana-
lyzed by GC/MS. Combined data collected from GC/MS spec-
tra afterweak and strongmethanolysis identified a 4,6-dideoxy-
4-(3-hydroxybutanoylamino)-hexose. Comparison with GC/MS
spectra obtained after similar treatment of P. stuartii O43
O-antigen samples (44), confirmed that the sugar possessed the
gluco configuration, representing viosaminewith 3-hydroxybu-
tyric acid substituting amino group at C4, referred to as
D-Qui4N(3HOBut) (Figs. 3 and 4). We used -elimination to
establish the character of the glycosidic bond between glycan
and the FliC peptide backbone. The -elimination releases gly-
FIGURE 2. Mass spectra of purified flagellin preparations. A, B. cenocepacia flagellin. B, chemically deglycosylated flagellin. C, nonglycosylated flagellin
purified from the BCAL0111 mutant strain. D, flagellin purified from strain MH43 (wbxD). Arrows indicate the difference of 231m/z between ions.
TABLE 3
Peptide ions identified after combining MS/MS data from tryptic, chymotryptic, and AspN/tryptic digests of B. cenocepacia FliC
Representative unmodified and modified ions are presented. Ions were confirmed in QTof and Orbitrap Elite analyses; (231) refers to glycan modification
Qui4N(3HOBut); oxidation refers to methionine (16 Da).
Start-End
Mr Oxidation
(16) SequenceObserved Calculated Expected
m/z
1–36 954.2421 3812.9393 3812.9915 Yes MLGINSNINSLVAQQNLNGSQNALSQAITRLSSGKR
37–52 773.3992 1544.7838 1544.7794 No INSAADDAAGLAISTR
53–90 992.7329 3966.9025 3966.9011 Yes (2 x) MQTQINGLNQGVSNANDGVSMIQTASSALSSLTNSLQR
91–106 840.9565 1679.8984 1679.8512 Yes IRQLAVQASTGTMSTT
107–137 1154.2551 3459.7435 3459.7230 No DQAALQQEVSQQIQEVNRIASQTTYNGTNIL
138–158 1010.5225 2019.0304 2019.0273 No DGSAGIVSFQVGANVGQTISL
159–168 519.2255 1036.4364 1036.485 No DLSQSMSAAK
159–168 527.2358 1052.4570 1052.4808 Yes DLSQSMSAAK
159–168 642.8051 1283.5956 1283.5677 Yes DLSQSMSAAK (231)a
169–176 386.2400 770.4654 770.4650 No IGGGLVQK
177–211 1118.2345 3351.6817 3351.6794 No GQTVGTVTGLSLDNNGAYTGSGATITAINVLSDGK
177–211 1195.2588 3582.7546 3582.7663 No GQTVGTVTGLSLDNNGAYTGSGATITAINVLSDGK (231)
187–206 1085.5468 2169.0790 2169.0199 No SLDNNGAYTGSGATITAINV (231)
187–211 813.7294 2438.1664 2438.1925 No SLDNNGAYTGSGATITAINVLSDGK
187–211 890.7588 2669.2546 2669.2794 No SLDNNGAYTGSGATITAINVLSDGK (231)
189–208 969.9615 1937.9084 1937.9330 No DNNGAYTGSGATITAINVLS
189–208 724.0175 2169.0307 2169.0199 No DNNGAYTGSGATITAINVLS (231)
189–217 1032.8304 3095.4694 3095.4333 No DNNGAYTGSGATITAINVLSDGKGGYTFT (231)
212–233 904.7971 2709.2692 2709.2659 No GGYTFTDQNGGAISQTVAQSVF (2 231)b
234–251 1055.0292 2108.0438 2108.0009 No GANATTGTGTAVGNLTLQ (2 231)a
252–286 1258.6530 3772.9372 3772.9331 No SGATGAGTSAAQQTAITNAIAQINAVNKPATVSNL (2 231)
287–321 1176.9285 3527.7637 3527.7637 Yes DISTVSGANVAMVSIDNALQTVNNVQAALGAAQNR
287–321 1253.9667 3758.8745 3758.8745 Yes DISTVSGANVAMVSIDNALQTVNNVQAALGAAQNR (231)
290–321 1148.9210 3443.7412 3443.7076 Yes TVSGANVAMVSIDNALQTVNNVQAALGAAQNR (231)
322–357 952.9465 3807.7569 3807.7381 Yes FTAIATSQQAESTDLSSAQSQITDANFAQETANMSK
359–382 849.4679 2545.3819 2545.4592 No QVLQQAGISVLAQANSLPQQVLKL
371–384 790.4595 1578.9044 1578.9093 No QANSLPQQVLKLLQ
a Data were obtained with QTof only.
b Data were obtained with Orbitrap Elite only.
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cans that form O-glycosidic bonds with serine or threonine,
leaving N-glycosidic bonds intact. D-Qui4N(3HOBut) was the
only sugar identified by GC/MS analysis of the sample after
-elimination (Fig. 4), demonstrating that B. cenocepacia FliC
was O-glycosylated. The structure of the glycan was also con-
sistent with the measured mass difference of 231 Da (theoreti-
calMr 249.1212, H2O 231.1106; Fig. 3).
Identification of the Genes Involved in FliC Glycosylation—
The flagellin gene fliC (BCAL0114) lies upstream of fliD
(BCAL0113), fliT (BCAL0112), BCAL0111, and BCAL0110.
The fliD and fliT encode the flagellar hook-associated protein
and a flagellar chaperone, respectively. BCAL0110 encodes a
putative VioA aminotransferase homologue (aminotransferase
involved in synthesis of Qui4N; Fig. 5A), and BCAL0111
encodes a predicted protein with homology to the group 1
superfamily of glycosyltransferases and also containing four
tetratricopeptide repeats. In silico analysis of BCAL0111 with
HHpred revealed a C-terminal domain of 360 amino acids that
is structurally homologous to several well characterized glyco-
syltransferases including the PimB mannosyltransferase from
FIGURE 3. Structure of the B. cenocepacia FliC glycan D-Qui4N(3HOBut).
FIGURE 4.GC/MS spectra aftermethanolysis and-eliminationofB. cenocepacia FliC glycan (K56-2) and control sample (O-antigenofP. stuartiiO43).
A, top two graphs correspond to an overview of entire spectra for P. stuartiiO43O-antigen and B. cenocepacia K56-2 FliC samples. Qui4N peaks at 13.8 and 14.4
(representing - and -configured derivatives) are indicated. Additional peaks detected in the O43 spectrum represent other sugars from the O-antigen (44).
Additional peaks in the FliC spectrum represent derivatized amino acids released from the FliC protein during methanolysis. The lower two spectra show the
characteristic fragmentation pattern of ions at 13.8 min (fragmentation pattern of ion at 14.4 min was identical). M corresponds to molecular weight of
derivatized Qui4N (303 Da). B, top graph shows an overview of the GC spectrum of the glycan released from FliC during -elimination. Inset shows the
derivatizedglycan (461Da)with the characteristic fragmentationpatternof the sugar and3-hydroxybutyric acid. Lower graph shows theMS/MS fragmentation
spectrum of the ion at 24.23 min. Differences between fragment ions () correspond to CH2CO (42), CH3CHO (44), CH3COO
 (59), and CH3COOH (60).
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Corynebacterium glutamicum (45), the human UDP-N-acetyl-
glucosamine peptideN-acetylglucosamine transferase (46), and
the WaaG lipid A-core biosynthesis glycosyltransferase (47).
To investigate whether BCAL0111 plays a role in FliC glycosyl-
ation, we constructed a BCAL0111 deletion mutant and ana-
lyzed its purified flagellin. Coomassie-stained SDS-PAGE of
FliC fromBCAL0111 showed a downshift in apparent molec-
ular size (Fig. 1C), which was also evident by Western blotting
with the RFFL/ARP42986_P050 antibody (Fig. 1B). Together,
these results demonstrated that flagellin biosynthesis can
proceed in the absence of glycosylation and that the antibody
was specific for B. cenocepacia flagellin regardless of its gly-
cosylation status. The MS spectrum of purified FliC from
BCAL0111 confirmed the loss of the glycan, as only a single
molecular ion of 38,756.90 m/z corresponding to nonglycosy-
lated flagellin could be detected (Fig. 2C). To confirm that
BCAL0111 is required for FliC glycosylation, we placed
BCAL0111 under the control of a rhamnose-inducible pro-
moter (Fig. 5A). FliC purified from a culture in rhamnose-con-
tainingmedium showed the samemolecularweight inMS anal-
ysis and Coomassie staining as the parental strain. In contrast,
flagellin isolated from a culture grown without rhamnose was
present only in its nonglycosylated state (Fig. 6, B and C).
Hence, we concluded that BCAL0111 is the FliC glycosyltrans-
ferase and designated the gene as flmQ for flagellin-modifying
protein that transfers D-Qui4N(3OHBut). The deletion of
BCAL0110 (vioA homologue) did not cause any detectable
defect in FliC glycosylation (see below).
The B. cenocepacia K56-2 LPS contains O-antigen. Glycans
from theO-antigenwere detected in our sugar analyses. There-
fore, we sought to delete the O-antigen genes to avoid this con-
tamination. Repeated attempts to delete genes between wbiI
(BCAL3119) and rmlB (BCAL3135; Fig. 5B) (15) failed (see
also below). However, a deletion including wbiI and wzm
(BCAL3131) was obtained and confirmed by PCR and SDS-
PAGE analyses of the LPS profile of the mutant strain (Fig. 7).
Analyses of FliC in the wbiI-wzm mutant showed the loss of
the flagellin glycan (Fig. 6A). Thus, we concluded that FliC gly-
cosylation requires one or more components of the O-antigen
cluster. Genes in the O-antigen cluster that could be involved
in the biosynthesis pathway of the FliC glycan are vioA
(BCAL3129), a nucleotide sugar aminotransferase from dTDP-
FIGURE 5.Geneorganizationof the fliC region (A) and theO-antigen clus-
ter (B) in B. cenocepacia.Deletionmutants are indicated by thick bars. Verti-
cal arrows indicate insertion sites of the rhamnose inducible pSC200 vector.
Genes showed as striped arrows encode the predicted enzymes required for
FliC glycosylation.
FIGURE 6.Mass spectra of flagellin fromvariousB. cenocepaciamutant strains.A,BCAL3119–3131; B, MH1KpSC200/BCAL0111grown in thepresence of
rhamnose; C, MH1K pSC200/BCAL0111 grown without rhamnose; D, BCAL3123–3124; E, BCAL3123–3124 pIN62/BCAL3123. Arrows indicate the mass of
231 Da.
FIGURE 7. Silver-stained 14% SDS-PAGE of whole cell lysates of B. ceno-
cepacia. Whole cell lysates from B. cenocepacia mutants were analyzed in
silver-stained 14%SDS-PAGE. The strains usedwere as follows:MH1K (lane 1);
BCAL3119–3131 (lane 2); BCAL3129 (lane 3); BCAL0110 (lane 4);
BCAL0111 (lane5);BCAL3123–24 (lane6);BCAS0105 (lane7);BCAS0105
pGPTp/rmlD (lane 8); and MH1K pGPTp/rmlD (insertional mutant inacti-
vating the last enzymatic step in dTDP-rhamnose biosynthesis; lane 9). Lad-
der-like bands (bracket) correspond to LPS-containing lipid A-core covalently
linked to O-antigen polysaccharides of varying length. Single bands in the
low molecular weight region (arrow) correspond to lipid A-core molecules
without O-antigen.
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D-Qui4N biosynthesis pathway (48) and wbxC (BCAL3123), a
putative acetyltransferase. No differences in flagellin glycosyla-
tion were detected in BCAL3129 compared with the parental
isolate (data not shown). Attempts to generate a single wbxC
deletion failed, but it was possible to delete this gene
together with the neighboring glycosyltransferase wbxD
(BCAL3124). Although the single wbxD deletion did not
affect FliC glycosylation (Fig. 2D), MS and SDS-PAGE anal-
yses of wbxCD revealed loss of glycosylation (Fig. 6D).
Introducing a functional wbxC on a plasmid (pIN62/wbxC)
into wbxCD restored FliC glycosylation (Fig. 6E). From these
results we concluded that wbxC is involved in the biosynthesis
of dTDP-D-Qui4N(3HOBut), possibly by catalyzing an acetyl-
transferase step prior to the formation of the 3-hydroxybutyric
acid side chain. This interpretation is consistent with the high
degree of homology in the primary amino acid sequence of
WbxC and the Acinetobacter baumannii WeeI protein, which
is an acetyltransferase involved in the biosynthesis of UDP-
N,N	-diacetylbacillosamine (49, 50). We did not succeed in any
attempts to construct a double deletion mutant eliminating
vioA (BCAL3129) and its putative homologue in the fliC region
(BCAL0110) despite using the same mutagenic plasmids that
were employed to delete both genes separately. However, it was
possible to delete BCAL0110 in the wbiI-wzm background and
conversely to delete the wbiI-wzm region in the BCAL0110
strain. These results demonstrate that both vioA and its
BCAL0110 homologue are nonessential genes (Fig. 5).
We also investigated the conservation of the genetic organi-
zation of the fliC region in otherBurkholderia species. A similar
gene organization as in J2315,with a putative flmQ (BCAL0111)
homologue placed downstream of fliCDT, was observed in B.
pseudomallei, Burkholderia mallei, Burkholderia glumae,
Burkholderia xenovorans, Burkholderia vietnamiensis, and
Burkholderia multivorans (Fig. 8A). B. thailandensis carries 11
additional genes inserted between the flmQhomologue and fliT
(Fig. 8B). In all these clusters, the flmQ homologue was
placed downstream from fliT and upstream from the puta-
tive vioA gene, which was a homologue of BCAL0110; no
other vioA homologues were found in these genomes. In B.
cepacia, the flagellin cluster has a unique organization (Fig. 8C),
where fliT is followed by a gene encoding a glycosyltransferase
(GEM_0145) and the flmQ homologue (GEM_0144), but in the
reverse orientation. Also inB. cepacia, the only BCAL0110 ami-
notransferase homologue (GEM_1565) is located outside of the
flagellin cluster. Despite the variations among different species,
the presence of homologous glycosyltransferase and amino-
transferase genes in their flagellin clusters suggests that flagellin
glycosylation is common in multiple species of the Burkhold-
eria genus. Indeed, it was reported that B. pseudomallei and B.
thailandensis produce glycosylated flagellin, but the glycan
described in these strains is different from the one identified
here (33).
RmlB Is an Essential Gene in B. cenocepacia—RmlB (dTDP-
D-glucose 4,6-dehydratase), one of the enzymes encoded by the
FIGURE8.Geneorganization in fliC clustersofotherBurkholderia species.The identity to flmQ is indicated inparentheses.A,B. pseudomallei668 (BURPS668;
49%), B. mallei NCTC 10247 (BMA10247; 49%), B. glumae (bglu_1g; 47%), B. xenovorans LB400 (Bxe_A; 49%), B. multivorans CGD2 (BURMUCGD2; 80%), B.
vietnamiensis AU4i (L810; 89%). B, B. thailandensis E264, dotted line represents 11 genes inserted between the putative fliT and flmQ (BCAL0111) homologues.
C, B. cepacia GG4. Genes showed as striped arrows represent BCAL0111 (flmQ) homologue, and aminotransferase represents a BCAL0110 homologue. GT,
glycosyltransferase.
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B. cenocepaciaO-antigen cluster, is needed for the synthesis of
dTDP-L-rhamnose, which in turn is required for the assembly
of the O-antigen repeating unit (Fig. 5B) (15). RmlB is also
responsible for producing the precursor for biosynthesis of
dTDP-D-Qui4N (51). In the course of these studies, we noticed
that rmlB (BCAL3135) could not be deleted, suggesting the
possibility that this gene is essential. To evaluate this notion, we
constructed a conditional mutant by placing the rhamnose-
inducible promoter upstream from rmlB. All tested strains,
including the control strains XOA10 (Prha::BCAL1928; nonle-
thal conditional mutant) and XOA11 (Prha::arnT; lethal condi-
tionalmutant) (17), grewwell when incubated onLB agar plates
with rhamnose. In contrast, only XOA10 grew well in the
absence of rhamnose, whereas XOA11 and the Prha::rmlB
strains grew very poorly (data not shown). The effect of rham-
nose depletion wasmuchmore dramatic in liquid cultures (Fig.
9). The rhamnose-inducible vector was also inserted upstream
from rmlC (BCAL3133) and rmlD (BCAL3132), which are down-
streamfrom rmlB, to examine their possible essentiality inB. ceno-
cepacia, but rhamnose depletion did not cause any growth alter-
ation in these strains (Fig. 9). Because BCAS0105, a gene
located in the third chromosome of B. cenocepacia, encodes a
putative RmlD homologue, rhamnose depletion experiments
were also performed in a BCAS0105 strain carrying Prha::rmlD.
These experiments indicated thatBCAS0105/Prha::rmlD is via-
ble under rhamnose-free conditions (Fig. 9), ruling out the pos-
sibility that BCAS0105 might have supplied the function of
rmlDwhen this gene was placed under the control of the rham-
nose-inducible promoter. Together, these results provide
experimental evidence that rmlB is essential in B. cenocepacia
K56-2.
Role of FliC Glycosylation on Bacterial Motility and Biofilm
Formation—In natural environments, flagella are bacterial
motility organelles. To examine the influence of flagellin glyco-
sylation onB. cenocepaciamotility, we tested themotility of the
deletion mutants on soft agar by measuring the diameter of
bacterial growth after 24 h of incubation at 37 °C. The strain
RSF44, which lacks flagella (38), did not migrate from the inoc-
ulation spot providing a negative control. Strain BCAL0111,
lacking the putative D-Qui4N(3HOBut) transferase flmQ,
showed a slight alteration in motility when compared with the
parental isolate (Fig. 10A), whereaswbxCD, missing the puta-
tive acetyltransferase and anO-antigen glycosyltransferase, had
a much stronger effect on motility. The wbiI-wzm mutant,
which causes complete loss ofO-antigen and the FliC glycan led
to an50% decrease in motility. Therefore, we conclude from
these results that flagellin glycosylation and a complete O-an-
tigen are required for normalmotility ofB. cenocepacia. Flagella
also contribute to biofilm production. When compared with
the parental strain, production of biofilmbyBCAL0111was at
a similar level as the flagella lacking strain RSF44 (Fig. 10B),
suggesting that the presence of glycosylation and not the fla-
gella alone is required for normal biofilm formation.
FliC Glycosylation Reduces TLR5-mediated Responses—To
examine the biological consequence of flagellin glycosylation in
innate immune responses, human THP1 monocyte cells were
stimulated with purified flagellins obtained from the parental
strain (glycosylated FliC) and the BCAL0111 mutant (nong-
lycosylated FliC). Stimulation of THP1 cells with both proteins
resulted in production of the pro-inflammatory cytokines
IL-1 (Fig. 11A), TNF- (Fig. 11B), and IL-6 (Fig. 11C). How-
ever, nonglycosylated FliC was significantly more efficacious
than the glycosylated counterpart in inducing IL-1, TNF-,
and IL-6. To eliminate the possibility that LPS contamination in
the flagellin preparations could confound these results, addi-
tional experiments were performed in HEK293 cells stably
expressing TLR5 (HEK293 cells normally lack Toll-like recep-
tors (52, 53)), which specifically recognizes flagellin. Again, the
nonglycosylated FliC was more effective in inducing pro-in-
flammatory cytokine production in TLR5 cells as indicated by
increased levels of IL-8 (Fig. 12A). We then looked at intracel-
lular signaling and showed that nonglycosylated FliC is also
more effective at activating NFB (as measured by induction of
a transfected NFB-regulated luciferase reporter gene; Fig.
12B) and the phosphorylation of the NFB subunit p65 (Fig.
12C). Also, nonglycosylated FliC mediated stronger phosphor-
FIGURE 9. Conditional lethal phenotypes of B. cenocepacia strains. Strains were cultured in LB supplemented with 0.5% (w/v) rhamnose (A) or without
rhamnose (B). After initial growth for 4 h (arrow), cultures were diluted 1:100 in fresh medium and incubated for 18 h.
FIGURE 10.Motility on soft LB agar plates (A) andbiofilm formation (B) of
B. cenocepacia strains.Data are representative of three independent exper-
iments. Statistical analysis was performed by paired t test using two-tailed p
values. Significant differences in comparison with B. cenocepacia parental
strain (WT) as control are indicated by ** (p
 0.01) or *** (p
 0.005).
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ylation of p38 MAPK (Fig. 12D). Together, these studies con-
sistently show that nonglycosylated FliC is more effective than
the glycosylated protein to stimulate pro-inflammatory signal-
ing by TLR5.
DISCUSSION
Despite the previously described roles for flagella in B. cenoce-
pacia pathogenicity (25, 26), this is the first report describing
flagellin glycosylation in this bacterium and identifying the genes
involved in the biosynthesis of the glycan. We showed that the B.
cenocepacia flagellin is modified with a viosamine (Qui4N)
derivative, D-Qui4N(3HOBut), on at least 10 glycosylation sites
within the protein. A sugar similar to D-Qui4N(3HOBut) but
carrying an additional methyl group at C2 (54) was previously
identified in glycosylated flagellin from Pseudomonas syringae
pv. tabaci (54, 55), whereas Qui4N itself is a component of the
flagellin glycan in Pseudomonas aeruginosa PAK (56). The bio-
synthesis of dTDP-viosamine requires three enzymatic steps as
follows: (i) conversion of D-glucose 1-phosphate into dTDP-D-
glucose, catalyzed by RmlA; (ii) formation of dTDP-4-dehydro-
FIGURE 11. Regulation of pro-inflammatory gene expression in THP1 cells by glycosylated and nonglycosylated forms of flagellin. THP1 cells were
stimulated for 24h in theabsence (NT, nontreated) orpresenceof varyingconcentrationsof fully glycosylatedwild-type (WT) or nonglycosylated (0111) forms
of flagellin, purified from the B. cenocepacia parental or BCAL0111 strains, respectively. Conditioned media were assayed for expression levels of IL-1 (A),
TNF- (B), and IL-6 (C). Data are representative of three independent experiments. Statistical analysis was performed by paired t test using two-tailed p values.
Significant differences between samples fromWT and 0111-treated cells are indicated by * (p
 0.05), ** (p
 0.01), or ***, (p
 0.001).
FIGURE 12. Differential stimulation of TLR5 signaling by glycosylated and nonglycosylated forms of flagellin. A, HEK293 cells, stably expressing TLR5,
were stimulated for 24 h in the absence (NT, nontreated) or presence of varying concentrations of fully glycosylatedwild-type (WT) or nonglycosylated (0111)
forms of flagellin purified from the B. cenocepacia parental orBCAL0111 strains, respectively. Conditionedmediumwas assayed for expression levels of IL-8.
B, HEK293 cells, stably expressingTLR5,were transfectedwith aNFB-regulated luciferase reporter geneand stimulated for 24has indicatedabove. Cell lysates
were assayed forNFB-regulated firefly luciferase activity, and fold induction levels ofNFB-regulated luciferase are expressed relative tonontreated (NT) cells.
Data are representative of three independent experiments. Statistical analysis was performed by paired t test using two-tailed p values. Significant differences
between samples fromWTand0111-treated cells are indicatedby * (p
 0.05). HEK293 cells, stably expressing TLR5,were stimulated for indicated timeswith
WT and 0111 flagellin (500 ng/ml). Cell lysates were immunoblotted for phosphorylated (p-) and total levels of p65 (C) and p38 (D), JNK and ERK MAPKs.
-Actin was used as a loading control.
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6-deoxy-D-glucose, catalyzed by RmlB; and (iii) an amination
step catalyzed by the dTDP-4-dehydro-6-deoxy-D-glucose
aminotransferase encoded by the vioA gene (57, 58). An addi-
tional step involves the acetylation of dTDP-viosamine to yield
dTDP-N-acetylviosamine. Homologues of vioA and vioB,
encoding the dTDP-viosamine acetyltransferase, have been
identified in P. syringae pv. tabaci (54) and P. aeruginosa PAK
(56), and both genes are required for the biosynthesis of the
modified viosamine in P. syringae pv. tabaci. Despite that in B.
cenocepacia there are two vioA homologues (BCAL0110 and
BCAL3129), we could not identify a vioB homologue. Instead,
we discovered that BCAL3123, encoding a putative acetyltrans-
ferase, is necessary for biosynthesis of D-Qui4N(3HOBut). Fur-
ther experiments are necessary to provide evidence whether
BCAL3123 encodes an enzyme catalyzing the direct transfer of
3OHBut or whether there are additional steps with BCAL3123
acting as an N-acetyltransferase prior to the formation of the
3OHBut side chain.
In particular, our results point to a complex link between
O-antigen biosynthesis and the biosynthesis of the flagellin gly-
can. Two genes required for flagellin biosynthesis are located in
the fliC gene cluster, whereas the other genes are present in the
O-antigen cluster. The flagellin gene cluster contains a vioA
homologue, which we show to be functionally redundant, and
the flmQ glycosyltransferase gene, which is essential for FliC
glycosylation. VioT, the flagellin glycosyltransferase in P. syrin-
gae pv. tabaci, has no homologues in B. cenocepacia, and con-
versely, P. syringae pv. tabaci has no FlmQhomologues. There-
fore, despite that both species use similar sugars for flagellin
glycosylation, the specific glycosyltransferases involved are
unique to each system, perhaps reflecting differences in the
FliC acceptor protein in each species. Comparison of fliC bio-
synthesis clusters in other Burkholderia species indicated the
presence of flmQ and vioA homologues just downstream from
fliC, with only a few exceptions. Flagellins fromB. pseudomallei
and B. thailandensis were previously found to be glycosylated
by a single glycan (33). Although the structures of the glycans
are unknown, theirmolecularmasses are 291 and 342Da for the
B. pseudomallei and B. thailandensis, respectively, suggesting a
different sugar than D-Qui4N(3HOBut). Therefore, we con-
clude that despite a common fliC gene cluster organization in
most Burkholderia species, the glycan structure and glycosyla-
tion pattern of flagellin is likely species-specific.
The discovery that rmlB is an essential gene inB. cenocepacia
was unexpected. In a previous study, Juhas et al. (59) reported
84 candidate essential genes in B. cenocepacia that were not
previously described as essential in any other bacteria. One of
these genes was rmlD (BCAL3132), located within the O-anti-
gen cluster, but these authors did not report any experimental
verification of rmlD essentiality. In our study, we conclusively
demonstrate that rmlB (BCAL3135), not rmlD, is essential for
B. cenocepacia viability. The B. cenocepacia dTDP-L-rhamnose
biosynthesis genes (rmlBACD) form one transcriptional unit
with the first 10 genes of O-antigen cluster (15). RmlB is a
dTDP-D-glucose 4,6-dehydratase, and its function is required
for the biosynthesis of nucleotide sugars like dTDP-D-fucose,
dTDP-L-rhamnose, dTDP-D-Qui4N, and several other metab-
olites (48, 51, 60, 61). In B. cenocepacia, rmlB is involved in the
synthesis of O-antigen, which contains rhamnose in its repeat-
ing unit (15), and in the synthesis of the D-Qui4N(3HOBut)
flagellin glycan, as we show here. However, O-antigen produc-
tion and flagellin glycosylation are not required for B. cenoce-
pacia viability. To our knowledge, RmlB has not been reported
as essential in other bacteria. The rlmB gene could not be
deleted in B. thailandensis, but its deletion was possible in B.
pseudomallei (33), suggesting it may be essential for at least
another Burkholderia species. We speculate that the RmlB
function may be required for the synthesis of another sugar
nucleotide that may play an essential role in an as yet unidenti-
fied metabolic pathway, perhaps becoming a novel attractive
candidate for antimicrobial development.
Although the flagellum is important for bacterial motility,
colonization, and virulence (21, 62, 63), the functional role of
glycosylation in host-bacteria interactions is less clear, and it
has only been investigated in a handful of bacterial species. For
example, nonglycosylated flagellin mutants of the plant patho-
gen P. syringae pv. tabaci are much less virulent on tobacco
leaves than the wild-type strain (54, 64, 65). In contrast, lack of
flagellin glycosylation does not affect the pathogenicity of star-
fruit pathogen P. syringae pv. averrhoi (66), whereas glycosy-
lated flagellin of Acidovorax avenae elicits a strong immune
response in cultured rice cells (67).
Contradictory results have also been reported for P. aerugi-
nosa glycosylated flagellins in their ability to modulate innate
immune responses in human epithelial cells (68, 69). Two noto-
rious human pathogens, Campylobacter jejuni and Helicobac-
ter pylori, cannot assemble flagella without glycosylation, and
lack of flagella in both strains significantly reduces their viru-
lence (70, 71). It is also not clear whether flagellin glycosylation
modulates TLR5 responses. The glycosylated flagellin from C.
jejuni is unique in that it fails to stimulate TLR5 (72). Reconsti-
tuting a functional TLR5-binding site in the C. jejuni flagellin
resulted in the expression of glycosylated flagellin that induces a
potent TLR5 response, ruling out a role for flagellin glycosylation
inC. jejuni evasion of TLR5 detection (72). The elucidation of the
flagellin glycosylation pathway in B. cenocepacia provided us with
the opportunity to directly test the role of glycosylation in
TLR5/flagellin-mediated inflammatory responses. We show
that nonglycosylated flagellin wasmore pro-inflammatory than
its fully glycosylated form. We also demonstrate that glycosyl-
ation of flagellin was associated with reduced efficacy with
respect to stimulating TLR5-mediated signal transduction and
gene expression. These results suggest that the presence of the
glycan may alter to some extent flagellin detection by TLR5,
although this was not directly examined here. We conclude that
flagellin glycosylation could provide B. cenocepacia a strategy to
reduce recognition by the innate immune system. However, fur-
ther experiments are required to assess in vivo the role of flagellin
glycosylation in the ability of these bacteria to cause chronic infec-
tion in cystic fibrosis patients.
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